Lin Bioscience

Lin Bioscience LT Debt/Equity

Long-Term Debt to Equity Ratio of Lin Bioscience (6696.TWO) as of Oct 11, 2026.

LT Debt/Equity

0.00

Last updated:

Long-Term Debt to Equity Ratio of Lin Bioscience is 2018 0.00 . Long-Term Debt to Equity Ratio of Lin Bioscience was 2017 0.00 . It decreases by % lower compared to the previous year.

The Lin Bioscience LT Debt/Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

LT Debt/Equity
Date
LT Debt/Equity
Jan 1, 2016
0.00 TWD
Jan 1, 2017
0.00 TWD
Jan 1, 2018
0.00 TWD
The Lin Bioscience LT Debt/Equity history
YEARLT Debt/EquityYoY
0.00—
0.00—
0.00—
Access this data via the Eulerpool API
Get Free API Key

Lin Bioscience Stock analysis

What does Lin Bioscience do? Lin Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lin Bioscience stock

On Eulerpool you can find the complete historical development of Long-Term Debt to Equity Ratio Lin Bioscience since 2006 – with annual values, charts, and detailed analysis.

The LT Debt/Equity ratio measures long-term financial leverage. It shows how much permanent debt capital is used relative to equity financing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Long-Term Debt to Equity Ratio's Lin Bioscience with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API
Get Free API Key

Leverage — Lin Bioscience

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Lin Bioscience